APA (7th ed.) Citation

J, L., M, X., Z, Z., T, G., Y, Q., Q, W., . . . Y, W. (2026). 18F-FDG-PET/CT-negative gastric cancer employs glutamine-based gluconeogenesis and fatty acid oxidation to support tumor growth. Cell death & disease, 17(1), . https://doi.org/10.1038/s41419-026-08662-9

Chicago Style (17th ed.) Citation

J, Liu, et al. "18F-FDG-PET/CT-negative Gastric Cancer Employs Glutamine-based Gluconeogenesis and Fatty Acid Oxidation to Support Tumor Growth." Cell Death & Disease 17, no. 1 (2026). https://doi.org/10.1038/s41419-026-08662-9.

MLA (9th ed.) Citation

J, Liu, et al. "18F-FDG-PET/CT-negative Gastric Cancer Employs Glutamine-based Gluconeogenesis and Fatty Acid Oxidation to Support Tumor Growth." Cell Death & Disease, vol. 17, no. 1, 2026, https://doi.org/10.1038/s41419-026-08662-9.